{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:57:42Z","timestamp":1775127462099,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2022QH1346"],"award-info":[{"award-number":["2022QH1346"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02139-x","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:24:36Z","timestamp":1775114676000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neutrophil extracellular Trap-related genes in NAFLD: Biomarkers and therapeutic targets"],"prefix":"10.1007","volume":"26","author":[{"given":"Huajing","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongcheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"4","key":"2139_CR1","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/hep.30848","volume":"70","author":"HW Lee","year":"2019","unstructured":"Lee HW, Wong VW. Changing NAFLD epidemiology in China. Hepatology. 2019;70(4):1095\u20138.","journal-title":"Hepatology"},{"issue":"18","key":"2139_CR2","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"A Sanyal","year":"2010","unstructured":"Sanyal A, Chalasani N, Kowdley K, McCullough A, Diehl A, Bass N, Neuschwander-Tetri B, Lavine J, Tonascia J, Unalp A, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362(18):1675\u201385.","journal-title":"N Engl J Med"},{"issue":"6","key":"2139_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, et al. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024;390(6):497\u2013509.","journal-title":"N Engl J Med"},{"issue":"3","key":"2139_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00428-022-03330-7","volume":"481","author":"S Arelaki","year":"2022","unstructured":"Arelaki S, Koletsa T, Sinakos E, Papadopoulos V, Arvanitakis K, Skendros P, et al. Neutrophil extracellular traps enriched with IL-1\u03b2 and IL-17A participate in the hepatic inflammatory process of patients with non-alcoholic steatohepatitis. Virchows Arch. 2022;481(3):455\u201365.","journal-title":"Virchows Arch"},{"issue":"4","key":"2139_CR5","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/hep.29914","volume":"68","author":"DJ van der Windt","year":"2018","unstructured":"van der Windt DJ, Sud V, Zhang H, Varley PR, Goswami J, Yazdani HO, Tohme S, Loughran P, O\u2019Doherty RM, Minervini MI, et al. Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology. 2018;68(4):1347\u201360.","journal-title":"Hepatology"},{"issue":"7","key":"2139_CR6","doi-asserted-by":"publisher","first-page":"e00466","DOI":"10.14309\/ctg.0000000000000466","volume":"13","author":"P Pettinelli","year":"2022","unstructured":"Pettinelli P, Arendt BM, Schwenger KJP, Sivaraj S, Bhat M, Comelli EM, et al. Relationship between hepatic gene expression, intestinal microbiota, and inferred functional metagenomic analysis in NAFLD. Clin Transl Gastroenterol. 2022;13(7):e00466.","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"2139_CR7","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/hep.27695","volume":"61","author":"BM Arendt","year":"2015","unstructured":"Arendt BM, Comelli EM, Ma DW, Lou W, Teterina A, Kim T, Fung SK, Wong DK, McGilvray I, Fischer SE, et al. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids. Hepatology. 2015;61(5):1565\u201378.","journal-title":"Hepatology"},{"issue":"2","key":"2139_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/gutjnl-2012-303179","volume":"63","author":"C L\u00f3pez-Vicario","year":"2014","unstructured":"L\u00f3pez-Vicario C, Gonz\u00e1lez-P\u00e9riz A, Rius B, Mor\u00e1n-Salvador E, Garc\u00eda-Alonso V, Lozano JJ, Bataller R, Cof\u00e1n M, Kang JX, Arroyo V, et al. Molecular interplay between \u22065\/\u22066 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. Gut. 2014;63(2):344\u201355.","journal-title":"Gut"},{"issue":"2","key":"2139_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","volume":"18","author":"M Ahrens","year":"2013","unstructured":"Ahrens M, Ammerpohl O, von Sch\u00f6nfels W, Kolarova J, Bens S, Itzel T, Teufel A, Herrmann A, Brosch M, Hinrichsen H, et al. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab. 2013;18(2):296\u2013302.","journal-title":"Cell Metab"},{"issue":"Database issue","key":"2139_CR10","first-page":"D991","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 2013;41(Database issue):D991\u2013995.","journal-title":"Nucleic Acids Res"},{"key":"2139_CR11","first-page":"1.30.31","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54:1.30.31-31.30.33.","journal-title":"Curr Protoc Bioinformatics"},{"issue":"12","key":"2139_CR12","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsd\u00f3ttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739\u201340.","journal-title":"Bioinformatics"},{"key":"2139_CR13","doi-asserted-by":"publisher","first-page":"1047367","DOI":"10.3389\/fimmu.2022.1047367","volume":"13","author":"J Wu","year":"2022","unstructured":"Wu J, Zhang F, Zheng X, Zhang J, Cao P, Sun Z, Wang W. Identification of renal ischemia reperfusion injury subtypes and predictive strategies for delayed graft function and graft survival based on neutrophil extracellular trap-related genes. Front Immunol. 2022;13:1047367.","journal-title":"Front Immunol"},{"issue":"6","key":"2139_CR14","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882\u20133.","journal-title":"Bioinformatics"},{"issue":"7","key":"2139_CR15","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W. Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2139_CR16","first-page":"383","volume":"99","author":"K Ben Salem","year":"2021","unstructured":"Ben Salem K, Ben Abdelaziz A. Principal Component Analysis (PCA). Tunis Med. 2021;99(4):383\u20139.","journal-title":"Tunis Med"},{"key":"2139_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2105-14-244","volume":"14","author":"H Zhang","year":"2013","unstructured":"Zhang H, Meltzer P, Davis S. RCircos: an R package for Circos 2D track plots. BMC Bioinformatics. 2013;14:244.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2139_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13148-019-0730-1","volume":"11","author":"S Engebretsen","year":"2019","unstructured":"Engebretsen S, Bohlin J. Statistical predictions with glmnet. Clin Epigenetics. 2019;11(1):123.","journal-title":"Clin Epigenetics"},{"issue":"5","key":"2139_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"key":"2139_CR20","doi-asserted-by":"publisher","first-page":"607622","DOI":"10.3389\/fonc.2020.607622","volume":"10","author":"B Xiao","year":"2020","unstructured":"Xiao B, Liu L, Li A, Xiang C, Wang P, Li H, Xiao T. Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma. Front Oncol. 2020;10:607622.","journal-title":"Front Oncol"},{"issue":"D1","key":"2139_CR21","doi-asserted-by":"publisher","first-page":"D43","DOI":"10.1093\/nar\/gkw965","volume":"45","author":"KR Zhou","year":"2017","unstructured":"Zhou KR, Liu S, Sun WJ, Zheng LL, Zhou H, Yang JH, Qu LH. ChIPBase v2.0: decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data. Nucleic Acids Res. 2017;45(D1):D43\u201350.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"2139_CR22","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92\u201397.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2139_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41592-021-01122-6","volume":"18","author":"A Singh","year":"2021","unstructured":"Singh A. RNA-binding protein kinetics. Nat Methods. 2021;18(4):335.","journal-title":"Nat Methods"},{"key":"2139_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.crtox.2021.08.001","volume":"2","author":"CJ Grondin","year":"2021","unstructured":"Grondin CJ, Davis AP, Wiegers JA, Wiegers TC, Sciaky D, Johnson RJ, Mattingly CJ. Predicting molecular mechanisms, pathways, and health outcomes induced by Juul e-cigarette aerosol chemicals using the Comparative Toxicogenomics Database. Curr Res Toxicol. 2021;2:272\u201381.","journal-title":"Curr Res Toxicol"},{"issue":"5","key":"2139_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.7150\/ijbs.14027","volume":"12","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Ma KL, Ruan XZ, Liu BC. Dysregulation of the low-density lipoprotein receptor pathway is involved in lipid disorder-mediated organ injury. Int J Biol Sci. 2016;12(5):569\u201379.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"2139_CR26","doi-asserted-by":"publisher","first-page":"e13985","DOI":"10.1016\/j.heliyon.2023.e13985","volume":"9","author":"E Gart","year":"2023","unstructured":"Gart E, van Duyvenvoorde W, Snabel JM, de Ruiter C, Attema J, Caspers MPM, Lek S, van Heuven BJ, Speksnijder A, Giera M, et al. Translational characterization of the temporal dynamics of metabolic dysfunctions in liver, adipose tissue and the gut during diet-induced NASH development in Ldlr-\/-.Leiden mice. Heliyon. 2023;9(3):e13985.","journal-title":"Heliyon"},{"key":"2139_CR27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141513","author":"Y He","year":"2021","unstructured":"He Y, Rodrigues RM, Wang X, Seo W, Ma J, Hwang S, et al. Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI141513","journal-title":"J Clin Invest"},{"issue":"3","key":"2139_CR28","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1021\/acs.accounts.9b00024","volume":"52","author":"S Mondal","year":"2019","unstructured":"Mondal S, Thompson PR. Protein arginine deiminases (PADs): biochemistry and chemical biology of protein citrullination. Acc Chem Res. 2019;52(3):818\u201332.","journal-title":"Acc Chem Res"},{"key":"2139_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe3771","author":"Y Wang","year":"2021","unstructured":"Wang Y, Lyu Y, Tu K, Xu Q, Yang Y, Salman S, et al. Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization. Sci Adv. 2021. https:\/\/doi.org\/10.1126\/sciadv.abe3771.","journal-title":"Sci Adv"},{"issue":"4","key":"2139_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/jcpe.13921","volume":"51","author":"SR Oliveira","year":"2024","unstructured":"Oliveira SR, de Arruda JAA, Schneider AH, Bemquerer LM, de Souza RMS, Barbim P, de Mattos-Pereira GH, Calderaro DC, Machado CC, Alves SF, et al. Neutrophil extracellular traps in rheumatoid arthritis and periodontitis: Contribution of PADI4 gene polymorphisms. J Clin Periodontol. 2024;51(4):452\u201363.","journal-title":"J Clin Periodontol"},{"key":"2139_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02036","volume":"9","author":"O Tatsiy","year":"2018","unstructured":"Tatsiy O, McDonald PP. Physiological stimuli induce PAD4-dependent, ROS-independent NETosis, with early and late events controlled by discrete signaling pathways. Front Immunol. 2018;9:2036.","journal-title":"Front Immunol"},{"issue":"6","key":"2139_CR32","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1165\/rcmb.2019-0433OC","volume":"63","author":"M Suzuki","year":"2020","unstructured":"Suzuki M, Ikari J, Anazawa R, Tanaka N, Katsumata Y, Shimada A, et al. PAD4 deficiency improves bleomycin-induced neutrophil extracellular traps and fibrosis in mouse lung. Am J Respir Cell Mol Biol. 2020;63(6):806\u201318.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2139_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cells11020236","author":"EGG Sprenkeler","year":"2022","unstructured":"Sprenkeler EGG, Zandstra J, van Kleef ND, Goetschalckx I, Verstegen B, Aarts CEM, et al. S100A8\/A9 is a marker for the release of neutrophil extracellular traps and induces neutrophil activation. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11020236.","journal-title":"Cells"},{"issue":"1","key":"2139_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4049\/jimmunol.1402709","volume":"196","author":"K Mukai","year":"2016","unstructured":"Mukai K, Miyagi T, Nishio K, Yokoyama Y, Yoshioka T, Saito Y, Tanaka S, Shigekawa M, Nawa T, Hikita H, et al. S100A8 Production in CXCR2-Expressing CD11b\u2009+\u2009Gr-1high Cells Aggravates Hepatitis in Mice Fed a High-Fat and High-Cholesterol Diet. J Immunol. 2016;196(1):395\u2013406.","journal-title":"J Immunol"},{"key":"2139_CR35","doi-asserted-by":"publisher","first-page":"792667","DOI":"10.3389\/fmolb.2021.792667","volume":"8","author":"H Xu","year":"2021","unstructured":"Xu H, Wang L. The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease. Front Mol Biosci. 2021;8:792667.","journal-title":"Front Mol Biosci"},{"issue":"6","key":"2139_CR36","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.7150\/ijbs.80122","volume":"19","author":"J Ding","year":"2023","unstructured":"Ding J, Xu M, Du W, Fang ZQ, Xu H, Liu JJ, Song P, Xu C, Li ZW, Yue ZS, et al. Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice. Int J Biol Sci. 2023;19(6):1941\u201354.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2139_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/hep.27394","volume":"61","author":"F He","year":"2015","unstructured":"He F, Guo FC, Li Z, Yu HC, Ma PF, Zhao JL, Feng L, Li WN, Liu XW, Qin HY, et al. Myeloid-specific disruption of recombination signal binding protein J\u03ba ameliorates hepatic fibrosis by attenuating inflammation through cylindromatosis in mice. Hepatology. 2015;61(1):303\u201314.","journal-title":"Hepatology"},{"key":"2139_CR38","doi-asserted-by":"crossref","unstructured":"Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 2001;292(5522):1728\u201331.","DOI":"10.1126\/science.292.5522.1728"},{"issue":"2","key":"2139_CR39","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.bbamcr.2011.09.017","volume":"1823","author":"W Luu","year":"2012","unstructured":"Luu W, Sharpe LJ, Stevenson J, Brown AJ. Akt acutely activates the cholesterogenic transcription factor SREBP-2. Biochim Biophys Acta. 2012;1823(2):458\u201364.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2139_CR40","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.7150\/ijbs.92337","volume":"20","author":"YC Wu","year":"2024","unstructured":"Wu YC, Yan Q, Yue SQ, Pan LX, Yang DS, Tao LS, Wei ZY, Rong F, Qian C, Han MQ, et al. NUP85 alleviates lipid metabolism and inflammation by regulating PI3K\/AKT signaling pathway in nonalcoholic fatty liver disease. Int J Biol Sci. 2024;20(6):2219\u201335.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"2139_CR41","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s10620-017-4470-9","volume":"62","author":"CX Cai","year":"2017","unstructured":"Cai CX, Buddha H, Castelino-Prabhu S, Zhang Z, Britton RS, Bacon BR, et al. Activation of insulin-PI3K\/Akt-p70S6K pathway in hepatic stellate cells contributes to fibrosis in nonalcoholic steatohepatitis. Dig Dis Sci. 2017;62(4):968\u201378.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"2139_CR42","doi-asserted-by":"publisher","first-page":"G211","DOI":"10.1152\/ajpgi.00040.2019","volume":"318","author":"DA Breuer","year":"2020","unstructured":"Breuer DA, Pacheco MC, Washington MK, Montgomery SA, Hasty AH, Kennedy AJ. CD8(+) T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2020;318(2):G211-24.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"2139_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hep4.1041","volume":"1","author":"J Bhattacharjee","year":"2017","unstructured":"Bhattacharjee J, Kirby M, Softic S, Miles L, Salazar-Gonzalez RM, Shivakumar P, et al. Hepatic natural killer T-cell and CD8\u2009+\u2009T-cell signatures in mice with nonalcoholic steatohepatitis. Hepatol Commun. 2017;1(4):299\u2013310.","journal-title":"Hepatol Commun"},{"issue":"5","key":"2139_CR44","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","volume":"112","author":"J Zhu","year":"2008","unstructured":"Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008;112(5):1557\u201369.","journal-title":"Blood"},{"issue":"8","key":"2139_CR45","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nm.2001","volume":"15","author":"S Winer","year":"2009","unstructured":"Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R, Wang Y, Zielenski J, Mastronardi F, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med. 2009;15(8):921\u20139.","journal-title":"Nat Med"},{"issue":"3","key":"2139_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10875-011-9635-2","volume":"32","author":"NE Ferreyra Solari","year":"2012","unstructured":"Ferreyra Solari NE, Inzaugarat ME, Baz P, De Matteo E, Lezama C, Galoppo M, Galoppo C, Cher\u00f1avsky AC. The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis. J Clin Immunol. 2012;32(3):611\u201321.","journal-title":"J Clin Immunol"},{"issue":"7","key":"2139_CR47","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.4049\/jimmunol.181.7.4656","volume":"181","author":"T Shimamura","year":"2008","unstructured":"Shimamura T, Fujisawa T, Husain SR, Kioi M, Nakajima A, Puri RK. Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model. J Immunol. 2008;181(7):4656\u201365.","journal-title":"J Immunol"},{"issue":"23","key":"2139_CR48","doi-asserted-by":"publisher","first-page":"33649","DOI":"10.18632\/oncotarget.9259","volume":"7","author":"Y Gao","year":"2016","unstructured":"Gao Y, Liu Y, Yang M, Guo X, Zhang M, Li H, Li J, Zhao J. IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis. Oncotarget. 2016;7(23):33649\u201361.","journal-title":"Oncotarget"},{"key":"2139_CR49","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.nut.2016.09.001","volume":"34","author":"T Charytoniuk","year":"2017","unstructured":"Charytoniuk T, Drygalski K, Konstantynowicz-Nowicka K, Berk K, Chabowski A. Alternative treatment methods attenuate the development of NAFLD: a review of resveratrol molecular mechanisms and clinical trials. Nutrition. 2017;34:108\u201317.","journal-title":"Nutrition"},{"issue":"5","key":"2139_CR50","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1017\/S0007114515002433","volume":"114","author":"F Faghihzadeh","year":"2015","unstructured":"Faghihzadeh F, Adibi P, Hekmatdoost A. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. Br J Nutr. 2015;114(5):796\u2013803.","journal-title":"Br J Nutr"},{"issue":"10","key":"2139_CR51","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","volume":"34","author":"F Faghihzadeh","year":"2014","unstructured":"Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res. 2014;34(10):837\u201343.","journal-title":"Nutr Res"},{"issue":"3","key":"2139_CR52","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.dld.2014.11.015","volume":"47","author":"S Chen","year":"2015","unstructured":"Chen S, Zhao X, Ran L, Wan J, Wang X, Qin Y, Shu F, Gao Y, Yuan L, Zhang Q, et al. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Dig liver disease: official J Italian Soc Gastroenterol Italian Association Study Liver. 2015;47(3):226\u201332.","journal-title":"Dig liver disease: official J Italian Soc Gastroenterol Italian Association Study Liver"},{"issue":"12","key":"2139_CR53","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.cgh.2014.02.024","volume":"12","author":"VS Chachay","year":"2014","unstructured":"Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O\u2019Moore-Sullivan TM, Lee P, Franklin M, Klein K, Taylor PJ, Ferguson M, et al. Resveratrol does not benefit patients with nonalcoholic fatty liver disease. Clin Gastroenterol hepatology: official Clin Pract J Am Gastroenterological Association. 2014;12(12):2092\u2013103. e2091-2096.","journal-title":"Clin Gastroenterol hepatology: official Clin Pract J Am Gastroenterological Association"},{"key":"2139_CR54","doi-asserted-by":"crossref","unstructured":"de Souza Andrade MM, Leal VNC, Fernandes IG, Gozzi-Silva SC, Beserra DR, Oliveira EA, Teixeira FME, Yendo TM, Sousa M, Teodoro WR et al. Resveratrol Downmodulates Neutrophil Extracellular Trap (NET) Generation by Neutrophils in Patients with Severe COVID-19. Antioxidants (Basel) 2022, 11(9).","DOI":"10.3390\/antiox11091690"},{"key":"2139_CR55","doi-asserted-by":"publisher","first-page":"102843","DOI":"10.1016\/j.ctim.2022.102843","volume":"68","author":"MH Ngu","year":"2022","unstructured":"Ngu MH, Norhayati MN, Rosnani Z, Zulkifli MM. Curcumin as adjuvant treatment in patients with non-alcoholic fatty liver (NAFLD) disease: A systematic review and meta-analysis. Complement Ther Med. 2022;68:102843.","journal-title":"Complement Ther Med"},{"issue":"1","key":"2139_CR56","doi-asserted-by":"publisher","first-page":"2164813","DOI":"10.1080\/08941939.2022.2164813","volume":"36","author":"C Zhu","year":"2023","unstructured":"Zhu C, Shi S, Jiang P, Huang X, Zhao J, Jin Y, Shen Y, Zhou X, Liu H, Cai J. Curcumin Alleviates Hepatic Ischemia-Reperfusion Injury by Inhibiting Neutrophil Extracellular Traps Formation. J Invest Surg. 2023;36(1):2164813.","journal-title":"J Invest Surg"},{"key":"2139_CR57","doi-asserted-by":"publisher","first-page":"115279","DOI":"10.1016\/j.biopha.2023.115279","volume":"165","author":"Y He","year":"2023","unstructured":"He Y, Wang H, Lin S, Chen T, Chang D, Sun Y, Wang C, Liu Y, Lu Y, Song J, et al. Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K\/AKT\/mTOR and HIF-1\/VEGF cascade. Biomed pharmacotherapy = Biomedecine pharmacotherapie. 2023;165:115279.","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"2139_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3201873","volume":"2019","author":"G Rodrigues","year":"2019","unstructured":"Rodrigues G, Moreira AJ, Bona S, Schemitt E, Marroni CA, Di Naso FC, et al. Simvastatin reduces hepatic oxidative stress and endoplasmic reticulum stress in nonalcoholic steatohepatitis experimental model. Oxid Med Cell Longev. 2019;2019:3201873.","journal-title":"Oxid Med Cell Longev"},{"key":"2139_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030716","author":"E Pereira","year":"2022","unstructured":"Pereira E, Araujo BP, Rodrigues KL, Silvares RR, Martins CSM, Flores EEI, et al. Simvastatin improves microcirculatory function in nonalcoholic fatty liver disease and downregulates oxidative and ALE-RAGE stress. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14030716.","journal-title":"Nutrients"},{"issue":"187","key":"2139_CR60","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.24976\/Discov.Med.202436187.158","volume":"36","author":"S Wang","year":"2024","unstructured":"Wang S, Li Z, Chang Y, Dong K, He D, Cheng X. Simvastatin inhibits the formation of NETs by the Mac-1 pathway to reduce hepatic ischemia-reperfusion injury under high-fat conditions. Discov Med. 2024;36(187):1721\u201331.","journal-title":"Discov Med"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02139-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02139-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02139-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:02:18Z","timestamp":1775124138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02139-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2139"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02139-x","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"209"}}